Evidence map›Paper›PMID 42539247›Full record

ArticleNeurotrauma reports

Perioperative Discontinuation of Antiplatelet and Anticoagulation Therapy in Chronic Subdural Hematoma: Impact on in-Hospital Mortality, Functional Outcome, and Recurrence.

Schahin Salmanian, Jan Rodemerk, Sali Al-Rubaiey, Madiha Ahmadzai, Elias Timner, Thiemo Florin Dinger, Oliver Gembruch, Ramazan Jabbarli, Philipp Dammann, Ulrich Sure and 1 more

Abstract read
In one paragraph

Article in Neurotrauma reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Schahin SalmanianDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Jan RodemerkDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Essen, Essen, Germany.
Sali Al-RubaieyFaculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Madiha AhmadzaiFaculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Elias TimnerFaculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Thiemo Florin DingerDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Oliver GembruchDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Ramazan JabbarliDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Philipp DammannDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Ulrich SureDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
Mehdi ChihiDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.ORCID https://orcid.org/0000-0003-2376-2211

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to evaluate the effect of perioperative discontinuation of antiplatelet and anticoagulation therapy (AAT) on in-hospital mortality, functional outcome, and recurrence in patients with chronic subdural hematoma (CSDH) with prior AAT use, compared to patients without AAT. We retrospectively analyzed data from patients with symptomatic CSDH who underwent surgery in our department between June 2012 and December 2023. Prior AAT was discontinued at hospital admission and reinitiated 3 weeks postoperatively if CSDH resolution was complete. Clinical and neurological status at admission and discharge were assessed using the modified Rankin Scale, with scores >3 defined as a poor outcome. Among 852 surgically treated CSDH patients (mean age 75.2 years; female-to-male ratio 1:2.1), univariate analysis revealed that prior AAT use was significantly associated with higher in-hospital mortality (

Indexed as

acetylsalicylic acidchronic subdural hematomarecurrencesurgical treatment

Identifiers

PMID42539247
PMCPMC13422604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.